No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.
Lancaster
Johnathan M
JM
Department of Obstetrics and Gynecology/Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Wenham
Robert M
RM
Halabi
Susan
S
Calingaert
Brian
B
Marks
Jeffrey R
JR
Moorman
Patricia G
PG
Bentley
Rex C
RC
Berchuck
Andrew
A
Schildkraut
Joellen M
JM
D000328:Adult; D000368:Aged; D000483:Alleles; D016022:Case-Control Studies; D003276:Contraceptives, Oral / Q000627:therapeutic use; D005260:Female; D005838:Genotype; D006801:Humans; D008875:Middle Aged; D009657:North Carolina / Q000453:epidemiology; D010051:Ovarian Neoplasms / Q000453:epidemiology* / Q000235:genetics*; D011110:Polymorphism, Genetic; D011980:Receptors, Progesterone / Q000235:genetics*; D012306:Risk
D003276:Contraceptives, Oral; D011980:Receptors, Progesterone